Charlton M - Search Results

1

Sofosbuvir and ribavirin for treatment of compensated recurrent hepatitis C virus infection after liver transplantation.

Charlton M, Gane E, Manns MP, Brown RS Jr, Curry MP, Kwo PY, Fontana RJ, Gilroy R, Teperman L, Muir AJ, McHutchison JG, Symonds WT, Brainard D, Kirby B, Dvory-Sobol H, Denning J, Arterburn S, Samuel D, Forns X, Terrault NA. Charlton M, et al. Gastroenterology. 2015 Jan;148(1):108-17. doi: 10.1053/j.gastro.2014.10.001. Epub 2014 Oct 7. Gastroenterology. 2015. PMID: 25304641 Clinical Trial.

2

A pilot study of the tolerability and efficacy of antiviral therapy in hepatitis C virus-infected patients awaiting liver transplantation.

Crippin JS, McCashland T, Terrault N, Sheiner P, Charlton MR. Crippin JS, et al. Liver Transpl. 2002 Apr;8(4):350-5. doi: 10.1053/jlts.2002.31748. Liver Transpl. 2002. PMID: 11965579 Free article. Clinical Trial.

3

Impact of cytomegalovirus infection, year of transplantation, and donor age on outcomes after liver transplantation for hepatitis C.

Burak KW, Kremers WK, Batts KP, Wiesner RH, Rosen CB, Razonable RR, Paya CV, Charlton MR. Burak KW, et al. Liver Transpl. 2002 Apr;8(4):362-9. doi: 10.1053/jlts.2002.32282. Liver Transpl. 2002. PMID: 11965581 Free article.

4

Treatment of posttransplantation recurrence of hepatitis C with interferon and ribavirin: lessons on tolerability and efficacy.

Narayanan Menon KV, Poterucha JJ, El-Amin OM, Burgart LJ, Kremers WK, Rosen CB, Wiesner RH, Charlton M. Narayanan Menon KV, et al. Among authors: charlton m. Liver Transpl. 2002 Jul;8(7):623-9. doi: 10.1053/jlts.2002.33968. Liver Transpl. 2002. PMID: 12089717 Free article.

5

Ultrasound-assisted percutaneous liver biopsy performed by a physician assistant.

Gunneson TJ, Menon KV, Wiesner RH, Daniels JA, Hay JE, Charlton MR, Brandhagen DJ, Rosen CB, Porayko MK. Gunneson TJ, et al. Am J Gastroenterol. 2002 Jun;97(6):1472-5. doi: 10.1111/j.1572-0241.2002.05789.x. Am J Gastroenterol. 2002. PMID: 12094868

6

Characterization of hepatitis B virus surface antigen and polymerase mutations in liver transplant recipients pre- and post-transplant.

Germer JJ, Charlton MR, Ishitani MB, Forehand CD, Patel R. Germer JJ, et al. Am J Transplant. 2003 Jun;3(6):743-53. doi: 10.1034/j.1600-6143.2003.00149.x. Am J Transplant. 2003. PMID: 12780567 Free article.

7

Natural history of hepatitis C and outcomes following liver transplantation.

Charlton M. Charlton M. Clin Liver Dis. 2003 Aug;7(3):585-602. doi: 10.1016/s1089-3261(03)00046-1. Clin Liver Dis. 2003. PMID: 14509528 Review.

8

Liver biopsy, viral kinetics, and the impact of viremia on severity of hepatitis C virus recurrence.

Charlton M. Charlton M. Liver Transpl. 2003 Nov;9(11):S58-62. doi: 10.1053/jlts.2003.50245. Liver Transpl. 2003. PMID: 14586897 Free article. Review.

9

Natural history and management of hepatitis C infection after liver transplantation.

Charlton M, Wiesner R. Charlton M, et al. Semin Liver Dis. 2004;24 Suppl 2:79-88. doi: 10.1055/s-2004-832932. Semin Liver Dis. 2004. PMID: 15346250 Review.

10

Long-term results and modeling to predict outcomes in recipients with HCV infection: results of the NIDDK liver transplantation database.

Charlton M, Ruppert K, Belle SH, Bass N, Schafer D, Wiesner RH, Detre K, Wei Y, Everhart J. Charlton M, et al. Liver Transpl. 2004 Sep;10(9):1120-30. doi: 10.1002/lt.20211. Liver Transpl. 2004. PMID: 15350002 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

833 results

Search Page

Filters